Synta Pharmaceuticals (SNTA) Posts Q4 Loss of 22c/Share; Revs Heavy
Tweet
Share
E-mailGet Alerts SNTA Hot Sheet
Price: $0.34 --0%
Financial Fact:
Total operating expenses: 14.09M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Financial Fact:
Total operating expenses: 14.09M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Join SI Premium – FREE
Synta Pharmaceuticals, Inc. (NASDAQ: SNTA) reported Q4 EPS of ($0.22), which may not compare with the analyst estimate of ($0.27). Revenue for the quarter came in at $3.42 million versus the consensus estimate of $2.32 million.
For earnings history and earnings-related data on Synta Pharmaceuticals, Inc. (SNTA) click here.
For earnings history and earnings-related data on Synta Pharmaceuticals, Inc. (SNTA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Nomura/Instinet Upgrades Genting Singapore (GENS:SP) (GIGNY) to Neutral
- Inhibrx, Inc. (INBX) Misses Q2 EPS by 54c
- Gemini Space Station, Inc. (GEMI) Misses Q2 EPS by 32c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
